Valuation: Epirus Biopharmaceuticals Inc

Market Cap 746K 655K 606K 558K 1.06M 71.43M 1.08M 7.23M 2.83M 35.08M 2.8M 2.74M 121M P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -15.94M -13.98M -12.95M -11.91M -22.53M -1.53B -22.97M -154M -60.51M -749M -59.84M -58.53M -2.59B EV / Sales 2014
14,770,294,750x
EV / Sales 2015 83,658,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+7.14%+7.14% - - 26
+0.44%+1.41%+4.25%+10.81% 50.73B
-3.00%-4.47%+373.03%+584.13% 39.73B
+0.96%+1.75%+30.88%-4.58% 34.69B
+1.62%-2.00%+20.27%+53.03% 33.21B
-0.06%-4.63%+2.94%+31.65% 26.76B
-2.39%-1.57% - - 16.8B
-0.94%-5.67%+66.38%+121.71% 15.37B
+0.78%+1.16%+15.53%+17.32% 13.78B
-0.49%-2.35%+11.64%-32.96% 12.85B
Average +0.38%-0.98%+65.61%+97.64% 27.1B
Weighted average by Cap. -0.29%-0.38%+80.33%+122.81%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.19 0.02 0.01 0.65 0.7 0.61 0.57 0.52 0.99 67.09 1.01 6.79 2.66 32.95 2.63 2.57 113.79
Net income -41.84M -36.7M -33.99M -31.28M -59.16M -4B -60.31M -405M -159M -1.97B -157M -154M -6.79B -52.19M -45.77M -42.4M -39.01M -73.78M -5B -75.22M -505M -198M -2.45B -196M -192M -8.47B
Net Debt -14.18M -12.44M -11.52M -10.6M -20.05M -1.36B -20.44M -137M -53.85M -666M -53.25M -52.08M -2.3B -16.68M -14.63M -13.55M -12.47M -23.58M -1.6B -24.04M -162M -63.35M -784M -62.64M -61.27M -2.71B
Logo Epirus Biopharmaceuticals Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-